You are now leaving this site and you'll be redirected to the Interbrand Global website.

Services

Drug Name Safety Testing

Ensure the efficacy of a drug name before it goes in front of the FDA by testing for language problems, benefit implications, “sound-alike” issues, and more.

Work

How Prozac brought depression out of the dark

Pharma brand naming for VPRIV

Strategic naming in pharma

Pharma brand naming for Bydureon

Pharma brand naming for XALKORI

Analytics for safety & success

Views

FDA news: Challenges in naming biosimilars

Suzanne Martinez

6 Challenges to Brand Naming in Pharma

Suzanne Martinez

4 Things You Need to Know About the FDA's Drug Naming Guide

John Breen and Lillian Smith

News

International Business Times explores drug names with InterbrandHealth

CNBC asks InterbrandHealth about challenges in drug naming

InterbrandHealth creative experts discuss drug naming

December 8, 2014

R. John Fidelino talks Prozac in New York Times Retro Report

September 21, 2014

InterbrandHealth on the art & science of drug naming

August 22, 2014

Slate: drug naming

August 22, 2013

John Breen leads analytics masterclass

Growth starts here